24 hours antibiotics
Phase 1
24 hours antibiotics is one of 28 therapeutic programs targeting Subarachnoid Hemorrhage. It is currently in Phase 1.
2
Indications
2
Total Trials
2
Active Trials
27
Competitors
Pipeline
Status by Indication[2][1]
Competition
Competitive Landscape
34 competitors in Subarachnoid Hemorrhage
#DrugCompanyPhaseTrials
1Cardene
Sun Pharmaceutical Industries, Inc.Approved
Keppra
UCBApproved
Olumiant
Eli LillyApproved
Pletal
OtsukaApproved
Xylocaine
MMEDRx USA, Inc.
Approved
Neurontin
VViatris Specialty LLC
Approved
Heparin Sodium
BBaxter Healthcare Corporation
Approved
Duragesic
CCephalon
Approved
Marcaine
IInnocoll
Approved
Angiomax
BBaxter Healthcare Corporation
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Urologic Surgery1 trial
Assessment of a 24-hour Preoperative Course of Antibiotic Therapy for Endoscopic Urological Surgery in Case of Positive Urine Culture
Not yet recruiting·GGCS Ramsay Santé pour l'Enseignement et la Recherche·Preclinical·NCT07206992·894 enrolled
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for 24 hours antibiotics. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1[1]
- Company
- MMontefiore Medical Center